Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Estrogen to Vulvar Vestibule for Dyspareunia
NCT03240081Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jun 2017
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol topical in dyspareunia (2 arms), sponsored by Oregon Health & Science University. Primary endpoints: Change in Median Dyspareunia Pain Scores at 4 weeks and Change in Median Pain Scores for Intercourse at 12 weeks. Started Jun 2017; status: completed.
02
Drugs
estradiol topical
03
Conditions
dyspareunia
Beyond the preview
Go deeper on NCT03240081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03240081.